This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Henke, A.
Right arrow Articles by Stelzner, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Henke, A.
Right arrow Articles by Stelzner, A.

 Previous Article  |  Next Article 

Journal of Virology, October 1998, p. 8327-8331, Vol. 72, No. 10
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

Protection of Mice against Lethal Coxsackievirus B3 Infection by Using DNA Immunization

Andreas Henke,1,* Elke Wagner,1 J. Lindsay Whitton,2 Roland Zell,1 and Axel Stelzner1

Institute of Virology, Medical Center, Friedrich Schiller University, 07745 Jena, Germany,1 and Department of Neuropharmacology, CVN-9, The Scripps Research Institute, La Jolla, California 920372

Received 17 February 1998/Accepted 16 June 1998

Vaccination with DNA and recombinant vaccinia viruses (rec.VV) has been studied with the coxsackievirus B3 (CVB3) model system. Plasmids encoding all structural proteins of CVB3, when injected intramuscularly, induced only low levels of virus-specific antibodies. However, DNA vaccination with the major structural protein VP1 protected 72.2% of mice from lethal challenge, whereas VP1 expressed by rec.VV was much less efficient.


* Corresponding author. Mailing address: Institute of Virology, Medical Center, Friedrich Schiller University, Winzerlaer Str. 10, 07745 Jena, Germany. Phone: (49) 3641 657215. Fax: (49) 3641 657202. E-mail: i6hean{at}rz.uni-jena.de.


Journal of Virology, October 1998, p. 8327-8331, Vol. 72, No. 10
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Dan, M., Chantler, J. K. (2005). A Genetically Engineered Attenuated Coxsackievirus B3 Strain Protects Mice against Lethal Infection. J. Virol. 79: 9285-9295 [Abstract] [Full Text]  
  • Merl, S., Michaelis, C., Jaschke, B., Vorpahl, M., Seidl, S., Wessely, R. (2005). Targeting 2A Protease by RNA Interference Attenuates Coxsackieviral Cytopathogenicity and Promotes Survival in Highly Susceptible Mice. Circulation 111: 1583-1592 [Abstract] [Full Text]  
  • Djilali-Saiah, I., Lapierre, P., Vittozi, S., Alvarez, F. (2002). DNA Vaccination Breaks Tolerance for a Neo-Self Antigen in Liver: A Transgenic Murine Model of Autoimmune Hepatitis. J. Immunol. 169: 4889-4896 [Abstract] [Full Text]  
  • Henke, A., Zell, R., Ehrlich, G., Stelzner, A. (2001). Expression of Immunoregulatory Cytokines by Recombinant Coxsackievirus B3 Variants Confers Protection against Virus-Caused Myocarditis. J. Virol. 75: 8187-8194 [Abstract] [Full Text]  
  • Slifka, M. K., Pagarigan, R., Mena, I., Feuer, R., Whitton, J. L. (2001). Using Recombinant Coxsackievirus B3 To Evaluate the Induction and Protective Efficacy of CD8+ T Cells during Picornavirus Infection. J. Virol. 75: 2377-2387 [Abstract] [Full Text]  
  • Peng, T., Li, Y., Yang, Y., Niu, C., Morgan-Capner, P., Archard, L. C., Zhang, H. (2000). Characterization of Enterovirus Isolates from Patients with Heart Muscle Disease in a Selenium-Deficient Area of China. J. Clin. Microbiol. 38: 3538-3543 [Abstract] [Full Text]  
  • Hassett, D. E., Slifka, M. K., Zhang, J., Whitton, J. L. (2000). Direct Ex Vivo Kinetic and Phenotypic Analyses of CD8+ T-Cell Responses Induced by DNA Immunization. J. Virol. 74: 8286-8291 [Abstract] [Full Text]